The Lancet. Oncology, ISSN: 1474-5488, Vol: 20,
Issue: 6, Page: 745-746
Digital
breast tomosynthesis, also known as three-dimensional mammography, has been
under investigation as a replacement for or complement to two-dimensional (2D)
digital mammography in breast cancer screening for some years, with several
prospective, population-based trials reporting increased cancer detection.1 So
far, published studies have been of paired design, in which each woman is her
own control—ie, imaged with both digital mammography and digital breast
tomosynthesis, read and reported in separate reading groups with either
stand-alone digital breast tomosynthesis, or digital breast tomosynthesis in
combination with digital mammography or so-called synthetic digital mammography
in the digital tomosynthesis group.
